Complete explanation of applicable patients and medications of Pemetinib

Pemetinib (Pemetinib) is a targeted drug targeting specific gene mutations and is widely used to treat cholangiocarcinoma and some relapsed or refractory tumors. This drug was developed by Incyte and is now widely used around the world. The following is a comprehensive explanation of its specific applicable patients and medication guidelines:

1. Applicable patients

1. Pemetinib is indicated for the treatment of adults with previously treated unresectable locally advanced or metastatic cholangiocarcinoma with experimentally detected fibroblast growth factor receptor2 (FGF R2) fusion or other rearrangement.

2. Pemetinib is indicated for the treatment of adults with relapsed or refractory myeloid/lymphoid neoplasms (MLNs) with fibroblast growth factor receptor1 (FGFR1) rearrangements.

2. Medication Operation Guide

1. Pre-medication genetic testing:

Before using pemetinib, patients need to undergo genetic testing to confirm the presence of tumorsFGFR2 fusion or related rearrangements, which is a key step to ensure the effectiveness of the drug.

2. Medication methods and dosage:

1) Pemetinib is an oral drug. It is recommended to swallow the tablet whole and avoid chewing or breaking it.

2) The recommended dose for patients with cholangiocarcinoma is13.5 mg, taken orally once a day for 14 consecutive days, and then stop treatment for 7 days, with a cycle of 21 days. Continue treatment until disease progression or unacceptable toxicity occurs. Take it at about the same time every day, with or without food.

3) The recommended dose for patients with myeloid/lymphoid neoplasms (MLNs) is 13.5 mg, taken orally once daily. Continue treatment until disease progression or unacceptable toxicity occurs. Take it at about the same time every day, with or without food.

3. Dose adjustment and monitoring:

During treatment, your doctor will adjust the dosage based on efficacy and side effects. At the same time, the patient's liver function, kidney function, etc. will be monitored regularly to ensure that the treatment is safe and effective.

4. Medication precautions:

1) Avoid drinking alcohol and using other drugs without doctor’s guidance during medication.

2) If you experience any discomfort or suspected drug side effects, please inform your doctor promptly.

In conclusion, pemetinib provides a new treatment strategy for patients with tumors with specific genetic mutations. When using it, patients should strictly follow the doctor's instructions to ensure the safety and effectiveness of the treatment. In addition, when choosing drugs, patients can purchase original drugs through formal channels in my country or choose more affordable generic drugs in the Lao market based on their own needs and economic status.